These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glutamatergic approaches to the treatment of cognitive and behavioural symptoms of Alzheimer's disease. Francis PT Neurodegener Dis; 2008; 5(3-4):241-3. PubMed ID: 18322401 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment of Alzheimer's disease: an update. DeLaGarza VW Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491 [TBL] [Abstract][Full Text] [Related]
7. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies. Tariot PN J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847 [TBL] [Abstract][Full Text] [Related]
8. [Alzheimer's disease: from brain lesions to new drugs]. Forette F; Hauw JJ Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689 [TBL] [Abstract][Full Text] [Related]
9. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease? Gauthier S; Poirier J Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447 [No Abstract] [Full Text] [Related]
10. Statins & Alzheimer's. Feinberg AW Health News; 2000 Dec; 6(12):1. PubMed ID: 11142934 [No Abstract] [Full Text] [Related]
11. Selegiline and vitamin E in Alzheimer's disease. Adelman A J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360 [No Abstract] [Full Text] [Related]
12. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2. Pham DQ; Plakogiannis R Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's treatment. Heart and brain. Sobel RK US News World Rep; 2002 Apr; 132(14):57. PubMed ID: 11989325 [No Abstract] [Full Text] [Related]
16. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Fillenbaum GG; Kuchibhatla MN; Hanlon JT; Artz MB; Pieper CF; Schmader KE; Dysken MW; Gray SL Ann Pharmacother; 2005 Dec; 39(12):2009-14. PubMed ID: 16227448 [TBL] [Abstract][Full Text] [Related]
17. Current approaches in the treatment of Alzheimer's disease. Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457 [TBL] [Abstract][Full Text] [Related]
18. Vitamin E and Alzheimer disease: the basis for additional clinical trials. Grundman M Am J Clin Nutr; 2000 Feb; 71(2):630S-636S. PubMed ID: 10681271 [TBL] [Abstract][Full Text] [Related]
19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
20. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]